Clinical Trials on Lung Cancer, Nonsmall Cell in United Kingdom
Total 7338 results
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)WithdrawnStage IIIA Non-Small Cell Lung CancerUnited States
-
University of California, DavisCompletedMETASTATIC NON-SMALL CELL LUNG CANCERUnited States
-
Theresa Whiteside, PhDImmune Cell Therapy Inc.TerminatedNon Small Cell Lung Cancer (NSCLC)United States
-
National Cancer Institute (NCI)CompletedExtensive Stage Small Cell Lung CancerUnited States
-
AstraZenecaActive, not recruitingNon-small Cell Lung Cancer NSCLCUnited Kingdom, Belgium, United States, Korea, Republic of, Hungary, Japan, Russian Federation, Poland, Ukraine, India, Mexico, Netherlands
-
MedImmune LLCCompletedNSCLC | Lung Cancer | Non-small Cell Lung CancerUnited States, France, Italy, Spain, Belgium, United Kingdom, Korea, Republic of, Australia, Taiwan
-
M.D. Anderson Cancer CenterActive, not recruitingStage III Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Neuroendocrine Carcinoma | Stage IIIC Lung Cancer AJCC v8 | Lung Small Cell CarcinomaUnited States
-
Memorial Sloan Kettering Cancer CenterJanssen Scientific Affairs, LLCActive, not recruitingMetastatic Non Small Cell Lung Cancer | Recurrent Non Small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterUniversity of WashingtonCompleted
-
New Mexico Cancer Care AllianceNovartis; Fred Hutchinson Cancer CenterCompletedNon-small Cell Lung CancerUnited States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
Aileron Therapeutics, Inc.TerminatedNon Small Cell Lung Cancer | Small-cell Lung CancerUnited States, Spain, Poland, Italy, Serbia, Bosnia and Herzegovina, Germany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingRecurrent Lung Non-Small Cell Carcinoma | Stage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7United States
-
NovaRx CorporationCompletedLung Neoplasm | Carcinoma Non-small Cell Lung Cancer Stage IIIA | Carcinoma Non-small Cell Lung Cancer Stage IIIB | Carcinoma Non-small Cell Lung Cancer Stage IVUnited States, Hungary, United Kingdom, Netherlands, Canada, India, Poland, Serbia
-
TelikCompletedNon-small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterAstraZeneca; Genentech, Inc.CompletedNon-small Cell Lung Cancer | EGFR-mutant Lung CancersUnited States
-
Yale UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; NextCure, Inc.RecruitingAdvanced Non-small Cell Lung CancerUnited States
-
Washington University School of MedicineXcovery Holdings, Inc.Active, not recruitingExtensive-stage Small Cell Lung CancerUnited States
-
Brown UniversityLifespanActive, not recruitingStage III Non-small-cell Lung CancerUnited States
-
Yale UniversityMerck Sharp & Dohme LLCCompletedNon-Small Cell Lung Cancer (NSCLC)United States
-
Check, Jerome H., M.D., Ph.D.Corcept TherapeuticsTerminatedNon-Small Cell Lung Cancer (NSCLC)United States
-
University of RochesterCelgene CorporationWithdrawnNon-small Cell Lung Cancer, Stage IIIUnited States
-
National Cancer Institute (NCI)CompletedLimited Stage Small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedExtensive-Stage Small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedStage IB Non-Small Cell Lung Carcinoma AJCC v7 | Stage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7United States
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Ireland, Italy, Mexico, Netherlands, Poland, Romania, Spain, Switzerland, United Kingdom
-
National Cancer Institute (NCI)TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Washington University School of MedicineAstraZeneca; Gateway for Cancer ResearchRecruitingExtensive-stage Small Cell Lung CancerUnited States
-
State University of New York - Upstate Medical...CompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Dartmouth-Hitchcock Medical CenterCTI BioPharmaCompletedAdvanced Non-small Cell Lung CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingStage III Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Stage IIIC Lung Cancer AJCC v8 | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States
-
Megan Daly, MDNational Cancer Institute (NCI); Genentech, Inc.TerminatedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, United Kingdom, Latvia, Italy, Israel, Argentina, Germany
-
Karen Reckamp, MD, MSEnviro Therapeutics, Inc.RecruitingLung Cancer | Non Small Cell Lung CancerUnited States
-
Teligene USRecruitingNon-small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminated
-
AbelZeta, Inc.Nektar TherapeuticsRecruiting
-
Washington University School of MedicineApollomics Inc.RecruitingMetastatic Non Small Cell Lung CancerUnited States
-
West Virginia UniversityWest Virginia Clinical and Translational Science InstituteCompletedNon Small Cell Lung Cancer MetastaticUnited States
-
Lyudmila Bazhenova, M.D.BeyondSpring Pharmaceuticals Inc.Active, not recruitingNon-small Cell Lung Cancer MetastaticUnited States
-
Albert Einstein College of MedicineCelldex TherapeuticsCompletedNon-small Cell Lung Cancer (NSCLC)United States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)CompletedStage IV Non-small Cell Lung CancerUnited States
-
University of Michigan Rogel Cancer CenterTerminatedAdvanced Non-Small Cell Lung CancerUnited States
-
The Cooper Health SystemUnknownUntreated Advanced Non-Small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung CancerSpain, Italy, Poland, Brazil, Turkey, Serbia, France, Korea, Republic of, Romania, Hungary, Russian Federation, United States, United Kingdom, Germany, Greece, Japan, Thailand, Ukraine, China
-
University of WashingtonNational Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Malignant Pleural EffusionUnited States
-
Duke UniversityCompletedA Study Osimertinib in Patients With Stage 4 Non-small Cell Lung Cancer With Uncommon EGFR MutationsNon Small Cell Lung CancerUnited States
-
Cell>Point LLCVenn Life Sciences; Biomedical Systems; Numoda; Camargo Pharmaceutical ServicesCompletedNon Small Cell Lung CancerUnited States
-
Emory UniversityBristol-Myers SquibbWithdrawnRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung CancerUnited States
-
SanofiCompletedSmall Cell Lung Cancer | Lung Cancer | Pulmonary NeoplasmsFrance, Brazil, Poland, Russian Federation, Australia, Germany, Italy, Spain, Belgium, Mexico, Argentina, Hungary, United Kingdom, Netherlands